Tower Research Capital (TRC)’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Tower Research Capital (TRC)’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-656	Closed	-$35K	–	5655
2016 Q1	$35K	Buy	+656	New	+$48.4K	0.01%	982
2015 Q3	–	Sell	-274	Closed	-$21K	–	5751
2015 Q2	$21K	Sell	274 -63	-19%	-$4.13K	﹤0.01%	2079
2015 Q1	$19K	Sell	337 -242	-42%	-$10.3K	﹤0.01%	2324
2014 Q4	$19K	Buy	+579	New	+$17.4K	﹤0.01%	1666
2014 Q1	–	Sell	-800	Closed	-$13K	–	5635
2013 Q4	$13K	Sell	800 -4,030	-83%	-$55.8K	﹤0.01%	2801
2013 Q3	$51K	Buy	4,830 +2,024	+72%	+$17.7K	0.01%	1909
2013 Q2	$16K	Buy	+2,806	New	+$17K	﹤0.01%	1956

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Tower Research Capital (TRC)'s ANAC Position: Q2 2016 in Review

Tower Research Capital (TRC) sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 656 shares — an estimated $35K sold.

Tower Research Capital (TRC) first reported a position in ANAC in Q2 2013 and held it in 7 quarters. The position peaked at $51K in Q3 2013. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Tower Research Capital (TRC) reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Tower Research Capital (TRC) sold 656 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $35K.
Tower Research Capital (TRC) first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 7 quarters.
Tower Research Capital (TRC)'s ANACOR PHARMACEUTICALS INC COM position peaked at $51K in Q3 2013.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.